The global cold plasma market size accounted for USD 2.87 billion in 2024, grew to USD 3.28 billion in 2025 and is projected to surpass around USD 10.93 billion by 2034, representing a healthy CAGR of 14.31% between 2024 and 2034. The North America cold plasma market size is calculated at USD 1.18 billion in 2024 and is expected to grow at a CAGR of 14.43% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cold Plasma Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cold Plasma Market Revenue and Volume, By Pressure, 2024-2034
8.1.1 Low-Pressure Cold Plasma
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Atmospheric Pressure Cold Plasma
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Cold Plasma Market Revenue and Volume, By Application, 2024-2034
9.1.1. Wound Healing
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Blood Coagulation
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Dentistry
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Cancer Treatment
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1.5. Other Medical Applications
9.1.5.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.1.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.2.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Pressure (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
11.1. US Medical Innovations
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Apyx Medical.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Adtec Healthcare Limited.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bovie Medical Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Neoplas Med GmbH
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Europlasma NV
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. P2i Ltd.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. terraplasma medical GmbH
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. CINOGY System GmbH
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample